The zeitgeist for medical manufacturers is not good.
Device-makers are having a terrible time getting new products that might give them pricing power approved by the FDA. Health reform adds a new 2.3% excise tax on many of the companies (though not lab equipment). And there’s demographic evidence that the number of baby boomers whose creaky knees and bad hearts fueled a decade of explosive growth for many medical manufacturers has peaked. Many of those patients are close to or already becoming cost-controlled Medicare patients.
Health reform points to a world of centralized rationing through Medicare and a return to capitated payments by private payers. This is not the time to be selling fancy new hospital equipment. From a societal standpoint, a slowdown in spending may not be a bad thing.
I don't quite understand that last sentence. It appears to be some misplaced editorializing.
But about those baby boomers, eh? What's the likelihood that the most self-indulgent generation the planet has ever known (until the next generation assumes its place, if it survives) is going to go quietly into "cost-controlled Medicare" patient-dom? With any luck, the geezers will burn the place down.
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | ||||||